SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Igor Brikun, Deborah Nusskern, Daniel Gillen, Amy Lynn, Daniel Murtagh, John Feczko, William G Nelson, Diha Freije, A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients, Biomarker Research, 2014, 2, 1

    CrossRef

  2. 2
    Charles Dariane, Chloé Le Cossec, Sarah J. Drouin, Benoit Wolff, Benjamin Granger, Pierre Mozer, Marc-Olivier Bitker, Shahrokh F. Shariat, Olivier Cussenot, Morgan Rouprêt, Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL, World Journal of Urology, 2014, 32, 2, 481

    CrossRef

  3. 3
    Yasuhide Kitagawa, Satoru Ueno, Kouji Izumi, Yoshifumi Kadono, Hiroyuki Konaka, Atsushi Mizokami, Mikio Namiki, Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1–10.0 ng/ml at population screening, Journal of Cancer Research and Clinical Oncology, 2014, 140, 1, 53

    CrossRef

  4. 4
    Kiyoshi Sawada, Yasuhide Kitagawa, Kazuto Ito, Yasuo Takeda, Atsushi Mizokami, Mikio Namiki, Cumulative risk of developing prostate cancer in men with low (≤2.0 ng/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan, International Journal of Urology, 2014, 21, 6
  5. 5
    Peter Qi, Matvey Tsivian, Michael R. Abern, Lionel L. Bañez, Ping Tang, Judd W. Moul, Thomas J. Polascik, Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5–4 ng/ml, Urologic Oncology: Seminars and Original Investigations, 2013, 31, 8, 1527

    CrossRef

  6. 6
    Paul R. McKenzie, Brett Delahunt, James G. Kench, Bronwen Ross, Que Lam, Kerry deVoss, Huy A. Tran, Kenneth A. Sikaris, Prostate specific antigen testing, Pathology, 2013, 45, 4, 343

    CrossRef

  7. 7
    Kyung Kgi Park, Seung Hwan Lee, Young Deuk Choi, Byung Ha Chung, Optimal Baseline Prostate-Specific Antigen Level to Distinguish Risk of Prostate Cancer in Healthy Men Between 40 and 69 Years of Age, Journal of Korean Medical Science, 2012, 27, 1, 40

    CrossRef